KERX Financial Facts
Net loss: -2.06MTotal research and development: 6.43M
See Full Income Statement
Total assets: 92.55M
Other current assets: 1.74M
See Full Balance Sheet
Earnings History for Keryx Biopharmaceuticals Inc. (KERX)
|
Expand Research on KERX
| Next EPS Date | 8/6/13 *Est. | EPS Growth Rate | +76.9% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -37.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +5.4% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/7/13 | Q113 | -$0.03 | -$0.01 | -$0.02 | $7M | $5.83M | N/A / N/A | N/A | +0.6% | Details | |
3/11/13  |
 |
Q412 | -$0.09 | -$0.08 | -$0.01 | N/A | N/A | N/A / N/A | N/A | +9.4% | Details |
| 11/8/12 |
Q312 | -$0.08 | -$0.07 | -$0.01 | N/A | N/A | N/A / N/A | N/A | +239.2% | Details | |
| 8/7/12 | Q212 | -$0.02 | -$0.09 | +$0.07 | N/A | N/A | N/A / N/A | N/A | +334.6% | Details | |
| 5/8/12 | Q112 | -$0.13 | -$0.12 | -$0.01 | N/A | N/A | N/A / N/A | N/A | +470.2% | Details | |
| 2/29/12 |
|
Q411 | -$0.12 | -$0.14 | +$0.02 | N/A | N/A | N/A / N/A | N/A | +142.2% | Details |
| 11/2/11 |
|
Q311 | -$0.15 | -$0.12 | -$0.03 | N/A | N/A | N/A / N/A | N/A | +162.7% | Details |
| 8/8/11 |
Q211 | -$0.05 | -$0.03 | -$0.02 | $5M | $5M | N/A / N/A | N/A | +131% | Details |
